Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
ConclusionsVaccination beyond recurrence of the disease with additional re-induction combined with surgery or alone increased long term survival of melanoma patients. However, further studies on larger patient cohorts are required.Trial registrationCentral Evidence of Clinical Trials (EudraCT Number2008 –003373-40)
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Genetics | Immunotherapy | Melanoma | Skin Cancer | Statistics | Stem Cell Therapy | Stem Cells | Study | Vaccines